相关实验视频
Updated: Jul 24, 2025

07:28
Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
Published on: July 2, 2018
9.2K
呈现不同临床结果和对血管压缩剂使用的反应的表现性心脏性休克:来自MIMIC-IV数据库的潜形状分析
Yue Yu1, Jin Rao1, Qiumeng Xu2
1Department of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai, China.
Frontiers in medicine
|July 10, 2023
概括
这项研究在急性心肌梗塞患者中确定了三种不同的心脏性休克 (CS) 现型. 不同的CS个人资料表现出不同的死亡风险和对血管压缩剂治疗的反应,突出了个性化治疗策略的必要性.
科学领域:
- 心脏病学 心脏病学
- 密集护理医学 密集护理医学
- 医疗信息学 医疗信息学
背景情况:
- 心脏性休克 (CS) 由于其严重程度和治疗反应的异质性而得到认可.
- 了解CS表型对于优化患者治疗结果至关重要.
研究的目的:
- 为了识别不同的心脏性休克 (CS) 现型.
- 调查CS表型与患者结果之间的关联.
- 分析CS表型对血管压缩剂治疗的差异反应.
主要方法:
- 隐形形状分析 (LPA) 用于识别CS表型.
- 使用多变量逻辑回归 (LR) 来评估血管压缩剂使用与死亡率之间的关联.
- 数据来源于医疗信息中心的重症监护IV (MIMIC-IV) 数据库,包括630名患有CS后急性心肌梗塞 (AMI) 的患者.
主要成果:
- 确定了三种CS表型:概况1 (基线),概况2 (老年,并发病,功能恶化) 和概况3 (SIRS相关的酸干扰).
- 个人资料3呈现出最高的住院死亡率 (45.9%),其次是个人资料2 (43.3%) 和个人资料1 (16.6%).
- 个人资料2和3独立地与增加住院死亡风险相关 (分别为OR3.95和3.90). 血管压缩剂在概况2和3中使用改善了死亡风险,但在概况1中没有.
结论:
- 存在不同的CS表型,其特点是不同的临床形状和预后.
- 现象型是CS患者结果的独立预测因素.
- 基于CS表型的定制血管压缩剂策略可能会改善患者的生存率.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
202
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
202
Blood Pressure Imbalances and Circulatory Shock
817
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
817
Cardiopulmonary Resuscitation IV: Pharmacological Management
26
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
26
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
121
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
121
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
1.1K
Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10

